Vision and Mission
Services
Team and Partners
For whom we work
News
Publications
Contact
Version imprimable de cet article Printable version

Daniel Lavanchy

Current position

2010-
Project manager and senior advisor in public health for viral hepatitis, smallpox, biosafety/biosecurity, and influenza

Major positions held

2001-2010
Project leader, coordinator, senior advisor
World Health Organisation (WHO), Geneva, Switzerland

1995-2001
Chief viral diseases
World Health Organisation (WHO), Geneva, Switzerland

1983-1995
Chef de secteur de recherche
CHUV, Division d’Immunologie et d’Allergie, Lausanne, Switzerland

Synopsis of experience

Editing, assessment and implementation of policies, regulations and recommendations. Advocacy. Team and consensus building.

International expert and consultant to governments and public/private institutions in the field of viral hepatitis, smallpox, influenza and biosafety/biosecurity covering laboratory diagnostics, treatments, vaccines and immunizations.

Experience in crisis management comprising epidemic investigations, implementation of emergency prevention and control activities, management of communications, provision of technical information and deployment of supplies (vaccines, drugs).

Evaluations/inspections of laboratories and maximum containment BSL-4 facilities.

More than twenty years of clinical experience in Swiss hospitals. More than fifteen years of work in clinical laboratories and clinical research.
Training to doctors and scientists from developed and developing countries.

Speaker in numerous national and international meetings and conferences; member of scientific juries; chairman of numerous meetings. More than 150 scientific publications; author of textbooks. Scientific reviewer for international journals.

More than two years of experience in the pharmaceutical industry.

Education and qualifications

2009
UNODA/CBRNE Training course for the UN Secretary General’s roster of qualified experts for investigation of alleged use of chemical, biological, and toxin weapons

2005
Courses in Pharmaceutical Economics and Policy Institute of Health Economics and Management (IEMS), University of Lausanne, Switzerland

2003-2005
Master in Health Economics and Management (MHEM). Institute of Health Economics and Management (IEMS), École des Haute Études Commerciales (HEC), University of Lausanne, Switzerland

1987
Specialist FMH in Internal Medicine
Specialist FMH in Allergy and Clinical Immunology

1977
Doctorate in medicine, University of Basel

1975
ECFMG

1975
Swiss federal diploma in medicine, University of Basel, Switzerland

News
Appeal to the Swiss Federal Council for an innovative financing model for the research on new antimicrobials
26 November 2017

On 9 November 2017, the Round Table on Antibiotics launched an appeal to the Federal Council to establish a dialogue in Switzerland between all partners involved in antibiotic research (academic research, economics, small and medium-sized enterprises, pharmaceutical industry, etc.). This dialogue should aim at defining, developing and implementing an innovative financing model for the research, development and marketing of new antibiotics that are financially accessible to all.

The text of the call of November 9, 2017 can be seen under "Publications"

The World Antibiotic Awareness Week will be held on 13-19 November 2017. Switzerland will participate.
8 November 2017

With the purpose of raising awareness of antibiotic resistance and improving the prudent use of antimicrobials, WHO (World Health Organisation) is organising a World Antibiotic Awareness Week since 2015. This year the event will be held from November 13 to 19. For the first time, Switzerland will actively participate to this week. Indeed, the crisis of bacterial resistance to antibiotics is such that an increasing number of infections is becoming difficult to treat, or even impossible. WHO is deeply concerned with this issue and is stimulating its state members to organise campaigns at the national level. Switzerland has already reacted to the antibiotic resistance issue by promoting a National Research Programme of 20 millions CHF(NRP 72) as well as a national Strategy on antibiotic resistance (StAR).

Additional information: StAR NRP72

FEMS 2017, the European microbiology congress, will be held in Valencia, Spain, July 9-13, 2017
29 December 2016

FEMS 2017, the 7th congress of FEMS (Federation of European Microbiological Societies) will be hosted by the Spanish Society for Microbiology (SEM). More than 2’000 participants from all over the world are expected in Valencia from July 9 to 13 to attend this event, which is offering 6 plenary lectures, 32 symposia, 24 workshops, poster discussion sessions, and several special events such as how to publish a paper, or from research to start-up creation, or education. All the domains of microbiology will be considered, including basic and applied research, environment and medical microbiology, microbial cell structure, genetics, antimicrobial resistance, mycology, virology, food microbiology, bioremediation, climate changes, etc..

Additional information: FEMS 2017

interlifescience   Via San Gottardo 92, 6900 Massagno, Switzerland - T : +41 91 960 05 55 - F : +41 91 960 05 56
ByteCode - informatique libre